FDA Recall United States TerminatedTerminated: August 14, 2020Historical recordClass II
Merical, LLC
- Product
- Meijer Joint Health Triple Strength Formula Glucosamine Hyd…
- Published
- February 12, 2020
- Distribution
- one customer , corporate in MI.
United States
TerminatedClass II
Product label does not contain Crustacean Shellfish on the ingredient list or allergen information
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Meijer Joint Health Movement Advanced Dietary Supplement with Glucosamine + Chondroitin. 1500 mg; Supports Joint Mobility and Comfort; Unit Size - 80 count - 2 tablets per day. Item Numbers: MEIJER7383 UPC Code: 713733562966 Distributed by Meijer Distribution Inc. Grand Rapids, MI | Not published in this source record | 977 cases | Meijer Product Packaging Lot Number / Merical Batch Numbers; 812923955/300-00023955 817223961/300-00023961 833727345/300-00027345 908727346/300-00027346 916828561/300-00028561 918929999/300-00029999 924630013/300-00030013 928830746/300-00030746 935331728/300-00031728 Expiration dates: 04/01/2020, 06/01/2020, 08/01/2020, 03/01/2021,05/01/2021, 06/01/2021, 08/01/2021, 09/01/2021, 12/01/2021 |
This recall shares FDA event ID 84690 with 1 other product entry in Public Health Trace.
FDA Recall United States TerminatedTerminated: August 14, 2020Historical recordClass II
Responsible company: Merical, LLC
FDA Recall United States OngoingHistorical recordClass I
FDA Recall United States TerminatedTerminated: August 14, 2020Historical recordClass II
FDA Recall United States TerminatedTerminated: March 6, 2020Historical recordClass III
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Michigan | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.
New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
FDA classifies this recall as Class II. See how to read an FDA recall record (linked above) for what each classification level means.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.
Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.
This record is preserved as published by FDA, as of August 14, 2020.
Status as reported: Terminated.
This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
Reconnecting to the server…
We lost the connection to the server.
Your session has expired.